Skip to Main Content

Paper Details

Irinophore Câ¿¢, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
J Control Release
15
2015

Datasets

Release 1.2